NDC62175-0617-46 — PANTOPRAZOLE SODIUM TABLETS

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC62175-0617-46: PANTOPRAZOLE SODIUM TABLETS.

The PANTOPRAZOLE SODIUM TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, special_features: PANTOPRAZOLE 40 MG TABLET, DELAYED RELEASE 90S; PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS, USP; 40 MG., long_action_method: DELAYED RELEASE, primary_container_type: BOTTLE, primary_container_content_quantity: 90.0 TABLETS, active_medicament_medicinal_strength: 40.0 MILLIGRAMS PANTOPRAZOLE SODIUM ACTIVE INGREDIENT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-672-5203, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC62175-0617-46

NSN: 6505-01-672-5203
FSC: 6505 — Drugs and Biologicals
CAGE: 6D0K6 — KREMERS URBAN PHARMACEUTICALS INC. DBA KREMERS URBAN PHARMACEUTICALS INC (USA)

SPECIFICATIONS

administration	ORAL
special_features	PANTOPRAZOLE 40 MG TABLET, DELAYED RELEASE 90S; PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS, USP; 40 MG.
long_action_method	DELAYED RELEASE
primary_container_type	BOTTLE
primary_container_content_quantity	90.0 TABLETS
active_medicament_medicinal_strength	40.0 MILLIGRAMS PANTOPRAZOLE SODIUM ACTIVE INGREDIENT
part_name_assigned_by_controlling_agency	PANTOPRAZOLE SOD DR 40 MG TAB USP 90S
NSN	6505-01-672-5203

COMPONENT DIAGRAM

KEY FEATURES

•

LONG ACTION METHOD: DELAYED RELEASE

•

ADMINISTRATION: ORAL

•

PRIMARY CONTAINER CONTENT QUANTITY: 90.0 TABLETS

•

PRIMARY CONTAINER TYPE: BOTTLE

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.0 MILLIGRAMS PANTOPRAZOLE SODIUM ACTIVE INGREDIENT

TECHNICAL CHARACTERISTICS

LONG ACTION METHOD	DELAYED RELEASE
ADMINISTRATION	ORAL
PRIMARY CONTAINER CONTENT QUANTITY	90.0 TABLETS
PRIMARY CONTAINER TYPE	BOTTLE
SPECIAL FEATURES	PANTOPRAZOLE 40 MG TABLET, DELAYED RELEASE 90S; PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS, USP; 40 MG.
PART NAME ASSIGNED BY CONTROLLING AGENCY	PANTOPRAZOLE SOD DR 40 MG TAB USP 90S
ACTIVE MEDICAMENT MEDICINAL STRENGTH	40.0 MILLIGRAMS PANTOPRAZOLE SODIUM ACTIVE INGREDIENT

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 3

6505NCM184212Reference document

Same NSN cross-reference

Reference document — Secondary reference

NDC51407-0613-90Same NSN cross-reference

Same NSN cross-reference

Also cataloged under this NSN

1510173Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC62175-0617-46?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC62175-0617-46?

NDC62175-0617-46 is a PANTOPRAZOLE SODIUM TABLETS.

What parts can replace NDC62175-0617-46?

There are 3 known substitutes for NDC62175-0617-46: 6505NCM184212, NDC51407-0613-90, 1510173. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC62175-0617-46?

NDC62175-0617-46 is cataloged in the U.S. Government catalog under NSN 6505-01-672-5203. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC62175-0617-46 — PANTOPRAZOLE SODIUM TABLETS

Request a Quote — NDC62175-0617-46